Dea Gowers Klauber

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

Anne Katrine Pagsberg, Pia Jeppesen, Dea Gowers Klauber et al. · The Lancet Psychiatry · 2017 · 51 citations

Psychiatry, Release Versus Aripiprazole, Psychotropic Medication +11

Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis

Karsten Gjessing Jensen, Christoph U. Correll, Ditte Rudå et al. · The Journal of Clinical Psychiatry · 2017 · 38 citations

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis (TEA) Trial

Karsten Gjessing Jensen, Christoph U. Correll, Ditte Rudå et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2019 · 23 citations

Cardiometabolic Adverse Effects, Psychiatry, Psychotic Disorder +10

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12–43 years

Birgitte Fagerlund, Christos Pantelis, Jens Richardt Møllegaard Jepsen et al. · Psychological Medicine · 2020 · 23 citations

Early Antipsychotic Nonresponse as a Predictor of Nonresponse and Nonremission in Adolescents With Psychosis Treated With Aripiprazole or Quetiapine: Results From the TEA Trial

Anne Katrine Pagsberg, Amanda Krogmann, Pia Jeppesen et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2022 · 22 citations

Tea Trial, Psychiatry, Psychotic Disorder +13